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The sensation of pain is associated with increased
mortality, but it is unknown whether pain perception
can directly affect aging. We find that mice lacking
TRPV1 pain receptors are long-lived, displaying a
youthful metabolic profile at old age. Loss of
TRPV1 inactivates a calcium-signaling cascade that
ends in the nuclear exclusion of the CREB-regulated
transcriptional coactivator CRTC1 within pain sen-
sory neurons originating from the spinal cord. In
long-lived TRPV1 knockout mice, CRTC1 nuclear
exclusion decreases production of the neuropeptide
CGRP from sensory endings innervating the pancre-
atic islets, subsequently promoting insulin secretion
and metabolic health. In contrast, CGRP homeo-
stasis is disrupted with age in wild-type mice,
resulting inmetabolic decline.We show that pharma-
cologic inactivation of CGRP receptors in old wild-
type animals can restore metabolic health. These
data suggest that ablation of select pain sensory re-
ceptors or the inhibition of CGRP are associated with
increased metabolic health and control longevity.
INTRODUCTION
The necessity for an organism to sense potentially harmful
stimuli in its environment has resulted in the evolution of recep-
tors and their associated signaling cascades designed to re-
cognize and appropriately respond to deleterious environments.
Neural receptors that detect noxious stimuli often trigger pain
sensations in order to promote avoidance and protect the organ-
ism from further harm. The transient receptor potential cation
channel subfamily V member 1 (TRPV1) is expressed in afferent
sensory neurons that detect extremely high temperatures and
painful stimuli in target tissues such as the dermal and epidermal
layers of the skin, the oral and nasal mucosa, and joints (Caterinaet al., 1997, 2000). The cell bodies of these neurons relay infor-
mation regarding environmental stimuli to the CNS via projection
to the dorsal horn of the spinal cord. In addition to their dimin-
ished pain sensitivity, another striking phenotype of TRPV1 null
mutant mice is their protection against diet-induced obesity,
suggesting a prominent role for TRPV1 in metabolism (Motter
and Ahern, 2008). Unmyelinated C-fibers expressing TRPV1
form a dense meshwork innervating the pancreas, and their
stimulation causes the release of neuropeptides, substance P,
and calcitonin gene-related peptide (CGRP), which promote
either neurogenic inflammation (Noble et al., 2006) or antagonize
insulin release in in vivo assays, respectively (Pettersson et al.,
1986). The relationship between the release of CGRP, aging,
and the overall health andmetabolism of the organism, however,
remains unknown.
The experience of pain necessarily causes a stress to the
organism, however, what remains unknown is the extent to
which the perception, rather than the experience of pain elicits
long-term consequences for the organism. Clinical studies
have observed a correlative decrease in lifespan and overall
decrease in health in patients that experience chronic levels
of pain (McBeth et al., 2003; Nitter and Forseth, 2013; Torrance
et al., 2010). Likewise, inversely, in invertebrates in which the
aging process is strongly affected by environmental factors,
alterations in canonical sensory perception can acutely influ-
ence normal aging. For example, ablation of sensory neurons
in the worm extends lifespan and mutations that impair chemo-
sensory signal transduction increase longevity in both worms
and flies (Alcedo and Kenyon, 2004; Apfeld and Kenyon,
1999; Libert et al., 2007). It is not known whether sensory
perception, and especially the activation of pain receptors
upon noxious stimulus, affects aging in mammals. Moreover,
the underlying molecular mechanisms behind the organism-
wide dissemination and reaction to this sensation, and its
consequence on organismal physiology, remain relatively
unknown.
In this study, we asked if reduced pain perception could
positively regulate mammalian aging by targeting evolutionary
conserved TRPVs. We provide evidence that mice lackingCell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc. 1023
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Figure 1. TRPV1 Disruption Extends Mouse Lifespan
(A and B) Kaplan-Meyer survival curves for wild-type (WT) and TRPV1 knockout (KO) mice are shown. (A) Male data. (B) Female data. Survival data are reported
in Table 1.
(C) Necropsy analysis. Incidence of neoplastic and nonneoplastic diseases. Results reported as percentage of mice showing occurrence of either neoplastic or
strictly nonneoplastic diseases (p < 0.1, ns, Fisher’s exact test).
(D) Nature of neoplastic diseases. Results reported as percentage (total number) of mice with the disease (*p < 0.05, Fisher’s exact test). ns, not significant,
na, not applicable.
See also Figure S1 and Tables S1 and S2.TRPV1 are long-lived and display a youthful metabolic profile at
old age. To understand the mechanism of this increased
longevity, we examined whether the chemosensory TRPVs of
Caenorhabditis elegans also played a role in aging. We find
that worm TRPVs function upstream of calcineurin to regulate
the transcriptional output of the nutrient sensing cAMP-respon-
sive element-binding protein, CREB, and its coactivator CRTC1.
Similarly, the lifespan extension of mice lacking TRPV1 appears
to be regulated by inactivation of the CRTC1/CREB pathway in
sensory neurons, conserved with results in the worm. Mechanis-
tically, we find that transcriptional activation of CRTC1/CREB in
TRPV1 neurons induces the release of the neuropeptide CGRP
that antagonizes insulin release from pancreatic b cells. Lastly,
our data indicate that genetic and pharmacological homeostasis
of CGRP restores metabolic health in old mice. We thus report
the discovery of a novel neuroendocrine circuitry that represses
longevity by adjusting the metabolic activity through the CRTC1/
CREB circuit.1024 Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc.RESULTS
Mice Lacking TRPV1 Are Youthful and Long-Lived
We asked if loss of TRPV1, the capsaicin receptor, altered
longevity in mice. To our surprise, animals lacking TRPV1 recep-
tors were exceptionally long-lived as indicated by their Kaplan-
Meier survival curves, median, and maximal lifespan (Figures
1A and 1B; Table 1). Under normal fed ad libitum conditions,
the TRPV1 mutation was not sex-specific in its effects: longevity
in both genders was extended to a similar extent, with 11.9%
increase in male TRPV1 mutants and 15.9% increase in median
female lifespan compared to wild-type, isogenic C57BL/6
controls (WT). On average, TRPV1 mutant males lived almost
100 days and TRPV1 mutant females lived 130 days longer
than control animals (mean lifespan, Table 1). Maximum lifespan
was strongly extended in female mutant mice.
We assessed cancer incidence by conducting postmortem
necropsy and histopathology (Figures 1C and 1D). The
Table 1. Comparative Survival Characteristics of TRPV1 Mutant
and WT Mice
n Median Min–Max Mean
Log Rank
Test
Max
Lifespan
Females
TRPV1
KO
48 946 685–1,156 957.48 ±
16.66
c2 = 18.35,
p < 0.0001
p < 0.001
WT 42 816 375–1,049 827.98 ±
18.47
Males
TRPV1
KO
38 1,038 780–1,226 1,036.31 ±
23.32
c2 = 9.92,
p < 0.001
ns
WT 32 927.5 614–1,187 937 ±
24.79prevalence of cancer tended to be reduced in TRPV1 mutant
versus control mice (Figure 1C). Neoplasms, which are the pri-
mary cause of death observed in our mouse cohort, comprised
a wide panel of cancer types (Figure 1D). Notably, the incidence
of hematopoietic neoplasia of lymphoid origin, the most
prevalent cancer observed in both genotypes, was reduced in
TRPV1 mutant animals. Other cancer types including sarcomas,
carcinomas, pituitary, and lung adenomas were also present in
both genotypes, however, the small number of observations
did not allow for any conclusion regarding the incidence of these
pathologies among genotypes. Furthermore, we did not observe
significant differences in the incidence of nonneoplastic dis-
eases between genotypes (Figure 1C; Table S1 available online).
Consistent with improved longevity and reduced aging,
30-month-old TRPV1 mutant mice displayed improved spatial
memory compared to their age-matched control animals when
challenged with a training, retention, and reversal paradigm in
a Barnes maze test (Figures S1A–S1C). Decline in motor coordi-
nation, measured by the latency to fall from a rotating rod, was
also delayed in the long-lived TRPV1 mutant mice (Figure S1D).
Because the presence of TRPV1 has been detected in the
hippocampus (Mezey et al., 2000; Sasamura et al., 1998), we
examined the neuronal density in the CA1, CA3, and dentate
gyrus (DG) areas of the hippocampus by Nissl staining (Fig-
ure S1E). The distribution of Nissl-positive neurons in these areas
was similar in WT and TRPV1 mutant mice, suggesting that
improved cognitive function in the TRPV1 mutants is not due
to increased neuronal numbers in the TRPV1 mutant animals,
but rather to a global improved healthspan in these mice.
Long-Lived TRPV1 Mutant Mice Do Not Have Reduced
Growth Rates or Altered IGF-1 Levels
Reduced growth hormone (GH) and/or insulin growth factor
(IGF-1) signaling have been tightly linked to longevity, often result-
ing in delayed growth and small adult animals (Blu¨her et al., 2003;
Ortega-Molina et al., 2012; Selman et al., 2008). We initially hy-
pothesized that the increased longevity and health of the TRPV1
mutant strain was caused by inactivation of the GH/IGF-1 axis.
Unlike GH/IGF-1 mice, TRPV1 mutant mice appeared similar in
size to WT mice (Figure 2A). Their growth curves were identical
to WT controls in both genders throughout aging (Figure 2B), in
contrast to mouse models with altered activity in either growthhormone (GH) or IGF-1 signaling (Blu¨her et al., 2003; Brown-
Borg et al., 1996; Coschigano et al., 2000, 2003; Flurkey et al.,
2001, 2002; Holzenberger et al., 2003; Ortega-Molina et al.,
2012; Selman et al., 2008, 2009; Zhang et al., 2012). Analysis
of body composition of age- and gender-matched controls
confirmed that organs including lung, liver, kidney, spleen,
pancreas, brain, heart, and different fat pads (inguinal, gonadal,
and retroperitoneal) were the same size in both genotypes (Fig-
ure 2C). Basic histological analysis by hematoxylin and eosin
(H&E) staining of key metabolic tissues (liver, white fat, heart) did
not reveal morphological differences between the wild-type and
TRPV1 mutant mice (Figure S2). Consistent with a normal body
weight, GH content in the pituitary was normal in the TRPV1
mutant adult mice (Figure 2D). In addition, plasma levels of IGF-
1,which is regulated byGH,were identical in both genotypes (Fig-
ure 2E). Therefore, loss of TRPV1 appears to modulate the aging
process in a mechanism independent of the GH/IGF-1 axis.
Long-Lived TRPV1 Mutant Mice Have a Youthful
Metabolic Profile
Altered metabolic programs have been associated with many
longevity pathways ranging from worms to mice. We investi-
gated whether the TRPV1 mutant mice had a distinct metabolic
profile in comparison to wild-type animals. Analysis of body tem-
perature, indicative of metabolic activity and reported to be low
in dietary restricted and long-lived Ames dwarf mice (Brown-
Borg et al., 1996), was unaffected in age-matched TRPV1mutant
mice compared to control animals (Figure S3A). Similarly, food
intake, which can influence lifespan through dietary restriction,
was unaffected (Figure S3A). A general assessment of blood fac-
tors indicative ofmetabolic activity revealed no difference in fast-
ing insulin levels, leptin, adiponectin, or circulating triglycerides
and cholesterol across genotypes (Figure S3B). There were no
alterations in the expression of brown fat-specific genes charac-
teristic of thermogenesis and brown fat development in the inter-
scapular brown adipose tissue (Figure S3C). However, we found
that TRPV1 mutant animals retained a youthful metabolic pro-
gram compared to age-matched control mice (Figure 3A). In
particular, the respiratory exchange ratio (RER), which measures
the daily transition from glucose to lipid metabolism, retained a
youthful circadian shift from night to day in old TRPV1 mutant
animals. At 3 months, both WT and TRPV1 mutant mice
displayed identical circadian oscillations from night to day. How-
ever, at late age, the TRPV1 mutants retained circadian transi-
tions of similar order of magnitude compared to that of young
mice, whereas WT animals lost their circadian shift. In fact,
decline in energy expenditure involving a lower RER is commonly
observed in old mice indicating that aging mice have a propor-
tional substrate preference toward fat (Houtkooper et al.,
2011). We clearly observe that the TRPV1 mutant mice do not
have this preference in late life.
Concurrent with improved metabolism, oxygen consumption
was enhanced in TRPV1 mutants at both young and old time
points compared to age-matched WT controls at the peak of
nocturnal activity (Figure S3D). TRPV1 mutants maintained their
VO2 maximum consumption late in life, in contrast toWT animals
that display a decline in maximum VO2 consumed with age.
Interestingly, we also found that voluntary activity was slightlyCell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc. 1025
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Figure 2. Evaluation of the Requirement of the GH/IGF-1 Axis in TRPV1 Mutant Mice
(A) Representative pictures of adult TRPV1 KO (6 months old, left: WT, right: TRPV1 KO).
(B) Whole-body growth of TRPV1 KO andWTmice from 3 to 24months old, (left) male data (TRPV1 KO, n = 38; WT, n = 32), (right) female data (TRPV1 KO, n = 48;
WT, n = 42). Means ± SEM, ns, two-way ANOVA.
(C) Body composition of 24-month-old TRPV1 KO andWTmales. Organweight of lungs, liver, kidney, spleen, pancreas, brain, heart, inguinal white adipose tissue
(iWAT), gonadal white adipose tissue (gWAT), and peritoneal white adipose tissue (pWAT) are expressed as a percentage of total body weight. Means ± SEM, ns,
Student’s t test.
(D) Western blotting of growth hormone (GH) from pituitary glands (n = 5 mice per lane, 6 months old). Loading control: b-actin.
(E) ELISA analysis of plasma IGF-1 levels in fed male mice (n = 15, 6 months old). Means ± SEM, ns, Student’s t test.
See also Figure S2.higher in young TRPV1 mutant animals but diminished to the
same extent asWTwhen old (Figure S3E). Taken together, these
data suggest than the youthful energy expenditure observed in
old TRPV1 mutant animals is not due to increased voluntary ex-
ercise, but appears to be due to more efficient maintenance of
metabolism with age.
Long-Lived TRPV1 Mutant Mice Have Altered Insulin
Metabolism
To uncover the mechanism underlying the youthful metabolic
phenotype of the TRPV1 mutant mice, we characterized the
glucose metabolic profile of these mice. We hypothesized that
TRPV1 mutant animals should be glucose tolerant as suggested
previously by studies focusing on chemo-denervation or phar-
macological inhibition of TRPV1 channels (Gram et al., 2007;
Tanaka et al., 2011). We found that TRPV1 mutant mice were
markedly more glucose tolerant than WT at 3 months and
22 months of age, which correspond respectively to ‘‘young’’
and ‘‘old’’ time points in a glucose tolerance test (GTT) (Fig-
ure 3B). Fasted glucose levels were unchanged between mutant
and wild-type mice. As improved glucose tolerance is often1026 Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc.associated with increased insulin sensitivity, we analyzed how
efficiently TRPV1 mutant mice were clearing blood glucose
after insulin injection through an insulin tolerance test (ITT) (Fig-
ure 3C). Despite improved glucose tolerance, we found that
blood glucose levels from young TRPV1 mutant mice decreased
by 40% following acute insulin challenge, contrary to a 67%
drop in WT controls. Both old WT and TRPV1 mutant mice
displayed age-onset insulin resistance, expressed by a dimin-
ished glucose response to insulin challenge relatively to the
young time point.
As insulin resistance is a hallmark of type 2 diabetes, leading to
b cell failure, we analyzed pancreatic islet morphology in adult
mice. We found no difference in islet architecture when staining
for insulin and glucagon in islets from mutant or wild-type mice,
suggesting that TRPV1 mutant islets are normal (Figure 3D).
Further investigation revealed that b cell mass was increased
in the TRPV1 mutant mice, suggesting that b cell survival was
improved in these mice independently of their proliferation or
neogenesis rate (Figures 3E and S3F). Gene expression of iso-
lated islet mRNA through quantitative real-time PCR (qRT-
PCR) did not reveal transcriptional differences between TRPV1
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Figure 3. Analysis of Whole-Body Energy Expenditure and Insulin Resistance
(A) Respiratory exchange ratio (RER) analysis of males TRPV1 KO and WT controls. n = 8, means ± SEM, ***p < 0.0001, one-way ANOVA.
(B) Glucose tolerance tests at 3 months and 22 months, n = 16, means ± SEM, ***p < 0.0001, **p < 0.001, *p < 0.01, Student’s t test.
(C) Insulin tolerance test at 3 months and 22 months expressed as a percentage of the initial glucose levels, n = 11–16, means ± SEM, **p < 0.001, *p < 0.01,
Student’s t test.
(D) Pancreata were fixed and immunolabeled against insulin (red) and glucagon (green), DAPI nuclear dye (blue).
(E) b cell mass of 24-month-old TRPV1 KO and WT mice, n = 4, means ± SEM, *p < 0.05, Student’s t test.
(F) Quantitative PCR analysis of isolated pancreatic islets from TRPV1 KO and WT mice, n = 8, means ± SEM, *p < 0.01, Student’s t test.
(G) Glucose stimulated insulin secretion assay, n = 5, means ± SEM, *p < 0.01, Student’s t test.
(H) Western blot analysis of phospho-AKT (Ser 473) and total AKT in TRPV1 KO andWTmuscle (left) and liver (right) in sham control () and insulin-stimulated (+)
mice, n = 5. a-tubulin and b-actin were respectively used as loading controls for muscle and liver tissues.
See also Figure S3.
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mutants and WT islet endocrine markers (Figure 3F). Levels of
glucagon (gcg), urocortin-3 (ucn3), amylin (amy), insulin-receptor
substrate 2 (irs2), the nuclear hormone receptor nr4a2, the fos
gene cFos, the ubiquitin carboxyl-terminal hydrolase 1 (usp1),
the regulator of G protein signaling 2 (rgs2), and peroxisome pro-
liferator-activated receptor gamma coactivator 1-alpha (pgc1a)
were unchanged across genotypes.
Because of the increased b cell mass observed in the TRPV1
mutant mice, we assumed that the improved glucose tolerance
was achieved through insulin hypersecretion in response to
glucose in order to compensate for their mild insulin resistance.
Consistent with this hypothesis, either chemo-denervation of
TRPV1 neurons or chemical inhibition of TRPV1 in rodents
increases glucose-dependent insulin secretion (Gram et al.,
2007; Tanaka et al., 2011). Indeed, qRT-PCR analysis of pan-
creatic islet mRNA revealed that the insulin gene (ins2) was
2-fold upregulated in the TRPV1 mutant cells. To directly
assess the link between TRPV1 and insulin secretion, we per-
formed a glucose stimulated insulin secretion experiment
(GSIS) where insulin levels are monitored upon glucose injection
(Figure 3G). We found that insulin release was significantly more
pronounced in TRPV1 mutant mice than WT, thus explaining the
improved glucose tolerance of TRPV1 mutants. Consistent with
TRPV1 mutant mice being healthy and not harboring symptoms
of type 2 diabetes, fasted insulin levels were similarly low as
compared to wild-type mice (Figures 3G and S3B). Therefore,
the TRPV1 mutant mice are not hyperinsulinemic, but rather
display an elevation in prandial insulin to respond more robustly
to glucose challenge.
To further investigate the nature of the insulin resistance of the
TRPV1mutant mice, we evaluated insulin-stimulated signaling in
liver and skeletal muscle by analyzing AKT phosphorylation,
which constitutes a downstream effector of the insulin receptor
pathway. Upon intravenous insulin injection, phosphorylation
of serine 473 of the serine/threonine kinase AKT protein was
unaltered in both tissues of the TRPV1mutant animals compared
to control animals (Figure 3H), indicating that insulin signaling is
functional in TRPV1 mutants in response to insulin.
Taken together, loss of TRPV1 results in long-lived mice that
are not growth-retarded and do not have altered IGF-1 levels
or responsiveness, yet have a youthful, metabolic profile with
increased glucose tolerance mediated by increased insulin
secretion upon glucose challenge. These data suggest that
impaired TRPV1 sensory neuron function has beneficial effects
on glucose homeostasis and longevity. Intrigued by the ability
of thesemice to live long by amechanism not canonical to estab-
lished longevity paradigms (GH/IGF-1 and dietary restriction),
we sought to uncover the mechanism by which TRPV1 neurons
could modulate this prolongevity signal.
C. elegans TRPV Regulates Lifespan through CRTC1/
CREB
Confronted with the complexity of the mammalian neuroendo-
crine system and its impact upon metabolism, we turned to the
nematodeC. elegans to reveal the possiblemechanism bywhich
TRPV1 could modulate metabolism and the aging process.
Despite a higher level of integration and compensation, the func-
tional organization of the mammalian chemosensory organs dis-1028 Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc.plays many striking similarities to worms at both anatomical
and signaling levels. Conserved signaling molecules include
members of the TRPV channel family. In worms, osm-9 and
ocr-2 function as a channel complex that transduces signals
from olfactory, nociceptive, and serotonergic neurons (Colbert
et al., 1997; Tobin et al., 2002; Zhang et al., 2004). Much like
the mouse, loss of TRPV in the worm resulted in increased
longevity (Figure 4A; Table S3). Using null mutants of both
osm-9(ky4) and ocr-2(ak47), we observed that loss of either
trpv resulted in a modest increase in longevity, consistent with
the functional redundancy of this receptor pair (Colbert et al.,
1997; Tobin et al., 2002; Zhang et al., 2004). However, loss of
both osm-9 and ocr-2 resulted in a robust extension of lifespan
up to 32% compared to control animals.
In response to ligands, TRPV receptors transduce signals
to the cytoplasm of affected cells through intracellular calcium
increase (Venkatachalam and Montell, 2007). One of the major
transponders of calcium flux in the cell is calcineurin (Mellstro¨m
et al., 2008). The worm calcineurin ortholog, the calcium-
activated calcineurin catalytic A subunit, tax-6, plays an intricate
role in theagingprocess (Donget al., 2007;Mair et al., 2011). Loss
of tax-6 results in long-lived animals and hyperactivation results
in short lifespan. One essential target of tax-6 to regulate the ag-
ing process in worms is the highly conserved crtc-1 (CREB-regu-
lated transcriptional coactivator 1). Dephosphorylation of CRTC1
on serines 76 and 179 by tax-6 results in nuclear localization,
modulation of CREB transcriptional targets and reduced
longevity. Opposing calcineurin, AMPKmonitors energy sources
and phosphorylates CRTC1, retaining CRTC1 in the cytoplasm.
Consistent with loss of tax-6 resulting in increased longevity,
increased activity of AMPK results in increased longevity through
phosphorylation of CRTC1 at serines 76 and 179, sites counter-
acted by tax-6 (Mair et al., 2011). While the circuitry downstream
of calcineurin to regulate longevity is well established, upstream
mediators of this pathway are unknown.
Because of the link between longevity and calcium regulation,
we asked if tax-6 and crtc-1 could function downstream of trpv-
mediated longevity. Upon tricaine treatment, a drug that
increases intracellular calcium in cells, CRTC1 shuttles to the
nucleus in wild-type animals, but remains strictly cytoplasmic
in tax-6(ok2065) mutants (Mair et al., 2011). Similarly to tax-6
mutant worms, trpv mutants (osm-9; ocr-2 double-mutant ani-
mals) retained cytoplasmic localization of CRTC1 upon tricaine
treatment (Figure 4B), indicating that TRPV functions upstream
within the tax-6/crtc pathway.
Consistent with TRPV functioning upstream in the calcineurin
pathway, the increased longevity caused by loss of trpv in the
worm was completely dependent upon the CRTC1 longevity
pathway. Inactivating tax-6, which extends lifespan in wild-
type animals, did not further increase the lifespan of the trpv
mutants (Figure 4C). Concordant with tax-6modulating longevity
through posttranslational modifications of CTRC1, we found that
the increased longevity of the trpvmutants was abrogated when
crtc-1 was mutated at the calcineurin dephosphorylation sites
S76A, S179A, making it constitutively nuclear (Figure 4D). There-
fore the lifespan extension caused by loss of trpv signaling was
completely dependent on nuclear exclusion of CRTC1 at the
same phosphorylation sites used for regulation by AMPK and
A B
C D
tricaineno treatment
CRTC1::RFP
osm-9(ky10); 
ocr-2(ak47)
WT, control RNAi
osm-9(ky10); ocr-2(ak47)
osm-9(ky10); ocr-2(ak47);
tax-6 RNAi
WT, tax-6 RNAi
CRTC1::RFP
WT
N2
osm-9(ky10); ocr-2(ak47) 
osm-9(ky10)
ocr-2(ak47)
4 8 12 16 20 24 28 32 36 40
0
20
40
60
80
100
Age (days)
%
 S
ur
vi
va
l
60
80
100
364 8 12 16 20 24 28 32
0
20
40
Age (days)
%
 S
ur
vi
va
l
CRTC1(S76A,S179A)::RFP
WT
osm-9(ky10);
ocr-2(ak47)
4 8 12 16 20 24 28 32
0
20
40
60
80
100
Age (days)
%
 S
ur
vi
va
l
Figure 4. trpv Mutations in C. elegans Require crtc-1 to Regulate Lifespan
(A) Survival curves of trpv double-null mutant worms osm-9 (ky10); ocr-2 (ak47) compared to single mutants.
(B) Representatives images of CRTC1::RFP cytoplasmic to nuclear shuttling in intestinal cells upon tricaine treatment in trpvmutant (osm-9 (ky10); ocr-2 (ak47))
worms and WT control.
(C) Survival curves of transgenic worms expressing CRTC1::RFP on calcineurin (tax-6) RNAi (dashed lines) compared to control worms fed GFPRNAi (plain lines).
(D) Survival curves of the trpv mutants in a constitutively nuclear crtc-1 strain mutated at the TAX-6 dephosphorylation sites (S76A, S179A) compared to WT
controls. All statistical analysis can be found in Table S3.calcineurin. Taken together, these results indicate that a subset
of chemosensory neurons utilizes a TRPV calcium signaling
cascade to adjust the worm metabolism to environmental
conditions by modulating CRTC1/CREB activity that ultimately
dictates longevity of the animal.
TRPV1 Regulates CRTC1/CREB in Mice
Intrigued by the finding that TRPV acts upstream of the calci-
neurin signaling cascade that regulates CRTC1/CREB to
profoundly affect aging in the worm, we asked if this same sys-
tem might be engaged in the long-lived TRPV1 mutant mice. We
examined the cellular distribution of the most abundant CREB-
regulated transcriptional coactivator in neuronal tissues,
CRTC1, in dissociated dorsal root ganglion (DRG) neuronal
cultures from TRPV1 mutant and wild-type mice (Figure 5).
Previous findings indicate that in hippocampal cultures,
CRTC1 shuttles to the nucleus of excitatory cells under glutama-
tergic synaptic activity using a calcium/calcineurin cascade
(Ch’ng et al., 2012; Kova´cs et al., 2007). The persistence of thenuclear localization of CRTC1 is regulated by cAMP levels. To
evaluate whether calcium and cAMP cascades regulate dynamic
shuttling of CRTC1 in DRG neurons, we analyzed the nuclear to
cytoplasmic trafficking of CRTC1 in the cell bodies of DRG neu-
rons isolated from TRPV1 mutants by pharmacologically manip-
ulating these pathways (Figure 5A). Immunoreactivity either
directly against TRPV1 or the TRPV1 comarker CGRP allowed
for recognition of small to medium-size nociceptor neurons
expressing TRPV1 (Bernardini et al., 2004; Caterina et al.,
1997; Price and Flores, 2007; Szallasi et al., 1995). We observed
CRTC1 immunoreactivity in peripheral DRG neurons, with a
cellular distribution similar to hippocampal cultures (Ch’ng
et al., 2012; Kova´cs et al., 2007). Indeed, under basal conditions,
CRTC1 localizes to axons, dendrites and the soma of the primary
neurons (Figure 5B). We then used the sodium channel blocker
Tetrodotoxin (TTX) to reduce endogenous synaptic activity and
prevent calcium entry through NMDA receptors. Under TTX
pretreatment, the distribution of CRTC1 remained mostly cyto-
plasmic as observed in basal conditions (Figure 5C).Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc. 1029
AD E
C
CGRP
DAPI
CRTC1
Merged
WT DRG
TTX CapFSK
TRPV1 KO DRG
TTX CapFSK
20 µm 20 µm 20 µm
TRPV1 CRTC1 DAPI Merged
20 µm
FSK CapCap
TRPV1
CRTC1
DAPI
Merged
+CsA+SB-366791
FSK
WT DRG
TTX
TT
X
FS
K
Ca
p
FS
K+
SB
-36
67
91
Ca
p+
SB
-36
67
91
FS
K+
Cs
A
Ca
p+
Cs
A
0
20
40
60
80
100 ***
***
***
%
N
uc
le
ar
WT
B
CRTC1P
P
Cytoplasm
Nucleus
↗ Ca2+
CaNSIKsAC
FSK
ATP
cAMP
P
P CRTC1
CRE
CREBCRTC1
CsA
KCl
CRTC1P
P
Cytoplasm
Nucleus
↗ Ca2+
CaN
TRPV1
Cap
P
P CRTC1
CRE
CREBCRTC1
SB-366791
CsA
TT
X
FS
K
Ca
p
0
20
40
60
80
100 ****** ***
%
N
uc
l e
ar
Pharmacological modulation of cyclic AMP signaling:
Pharmacological modulation of TRPV1 activity:
ga
pd
h
-ac
tin
β c
alc
a
tac
1
cfo
s
no
s1
bd
nf
nr4
a2
nr4
a3 rgs
2
hp
rt arc eg
r1
0.0
0.5
1.0
1.5
TRPV1 KO
WT
* * * * * *
Fo
ld
c h
an
ge
TRPV1 KO
WT
Figure 5. Nuclear Translocation of CRTC1 Requires Activation of TRPV1
(A) Schematic representing the modulation of cAMP signaling and TRPV1 activity on CRTC1 shuttling in DRG neurons upon the pharmacological manipulations
used in (B–D). Maximal projections of z stack sections throughout the nucleus of the neuronal bodies.
(B) Wild-type mouse DRGs primary cultures were immunostained with antibodies against TRPV1 (red), CRTC1 (green), DAPI (blue).
(C) Left: DRG neuronal cultures were subjected to FSK (25 mM), agonist of L-type calcium channels inducing cAMP release, and Cap (1 mM), a potent TRPV1
agonist. Immunostaining was performed after fixationwith antibodies against CGRP (red), CRTC1 (green), DAPI (blue). Right: quantification of themean nuclear to
cytoplasmic ratio, relative to vehicle treatment. n = 90–120 cells analyzed, means ± SEM, ***p < 0.0001, Student’s t test.
(D) Left: WT DRGs cultures were pretreated with vehicle, the calcineurin inhibitor CsA (10 mM) and the TRPV1 antagonist SB-366791 (10 mM) prior to 1 hr
stimulation with FSK and Cap. Neurons were fixed and immunostained with antibodies against TRPV1 (red), CRTC1 (green), DAPI (blue). Right: quantification of
the mean nuclear to cytoplasmic ratio, relative to vehicle treatment. n = 90–120 cells analyzed, means ± SEM, ***p < 0.0001, Student’s t test.
(E) Quantitative PCR analysis was carried out to examine CREB-dependent transcript induction in untreated DRG neurons from TRPV1 KO and WT, n = 7,
means ± SEM, *p < 0.05, Student’s t test.To establish conditions to monitor CRTC1 shuttling, stimula-
tion of the neurons with a combination of Forskolin (FSK), which
raises cAMP levels therefore decreasing CRTC phosphorylation
(Kova´cs et al., 2007; Screaton et al., 2004), and KCl, which trig-
gers calcium entry and activation of calcineurin resulting in CRTC
dephosphorylation, induced CRTC1 nuclear entry in WT and
TRPV1 mutant DRG cells and served as our positive control
(Figure 5C).
Activation of L-type voltage-gated calcium channels
(LVGCCs) provokes robust calcium currents in neurons and
results in hippocampal CRTC1 shuttling (Ch’ng et al., 2012).1030 Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc.To test whether activation of TRPV1 and subsequent calcium
entry were modulating CRTC1 directly, we applied a natural
TRPV1 agonist, Capsaicin (Cap) to DRG neurons and
observed accumulation of CRTC1 in the nuclei of CGRP-
positive cells of WT DRGs cultures (Figure 5C). The nuclear
entry was similar to treatment with FSK and KCl (Figure 5C).
More importantly, Cap-induced CRTC1 shuttling was abol-
ished in TRPV1 mutant DRG neurons (Figure 5C). As an addi-
tional test of TRPV1’s role in CRTC1 nuclear shuttling,
blockade of TRPV1 by a selective chemical antagonist of
TRPV1 (SB-366791) resulted in robust nuclear exclusion of
CRTC1 in WT DRG neurons (Figure 5D), much like that found
in TRPV1 mutant DRG neurons.
These findings demonstrate that calcium entry through TRPV1
is sufficient to promote nuclear redistribution of CRTC1 and
is likely to cause calcineurin activation. To examine the require-
ment of the calcineurin pathway downstream of TRPV1, we incu-
bated the DRGneurons with the calcineurin inhibitor Cyclosporin
A (CsA). As observed previously in hippocampal cells (Kova´cs
et al., 2007), CsA prevented FSK+KCl-mediated CRTC1 nuclear
accumulation in TRPV1 positive DRG neurons (Figure 5D). CsA
pretreatment also inhibited Cap’s ability to force CRTC1 into
the nucleus in WT DRG neurons (Figure 5D). Taken together,
our data clearly indicate that TRPV1 is a potent regulator of
CRTC1 shuttling via calcineurin activity in both invertebrates
and vertebrates.
TRPV1 Regulates CREB Target Genes in DRGs
The ability of CRTC1 to shuttle to the nucleus under TRPV1
activity demonstrates the existence of a plastic transcriptional
mechanism adapting rapidly to external outputs. The nuclear
exclusion of CRTC1 in TRPV1 mutant DRG neurons suggests
that CREB transcriptional activity is likely to be altered in the
DRG neurons of TRPV1mutant mice. Under inflammatory condi-
tions, TRPV1 expressing DRG neurons utilize a CREB signaling
cascade to induce neurogenic inflammation through the release
of CGRP, by the binding of CREB onto the CGRP promoter
(Nakanishi et al., 2010). We hypothesized that in the TRPV1
mutant mice, CREB transcriptional activity is downregulated
due to the nuclear exclusion of CRTC1. Indeed, mRNA expres-
sion analysis fromDRGneurons revealed that previously charac-
terized CREB target genes were reduced in long-lived TRPV1
mutants compared to wild-type animals (Figure 5E).
CGRP, but Not Substance P, Regulates Insulin Secretion
The long-lived TRPV1 mutant mice enjoy a youthful metabolic
program characterized by improved glucose homeostasis due
to increased insulin secretion upon glucose challenge. Because
the DRG neurons form a dense meshwork innervating pancre-
atic b cells (Akiba et al., 2004; Razavi et al., 2006), we hypoth-
esized that the TRPV1 neurons within the DRG might secrete
a factor that inhibits insulin release from pancreatic b cells,
thereby establishing accurate insulin homeostasis. Further-
more, because CRTC1 localization is altered in the TRPV1 neu-
rons, we speculated that the secreted factor(s) that stem from
TRPV1 neurons in the DRG might be under transcriptional
control by CRTC1/CREB. In our analysis of CREB regulated
genes within DRG neurons, the induction of calcitonin-related
polypeptide a (calca) and tachykinin 1 (tac1) transcripts, pre-
cursors of two TRPV1 secreted neuropeptides, CGRP and
substance P, respectively, were reduced in the TRPV1 mutant
mice (Figure 5E). Therefore, we asked whether either sub-
stance P or CGRP could affect insulin secretion from pancre-
atic b cells.
To mimic pancreatic b cell glucose-mediated insulin release,
we used mouse insulinoma MIN6 cells (Huising et al., 2010).
When stimulated with 16.8 mM of glucose, MIN6 cells release
up to 150 ng/ml of insulin. However, when the same cells are
treated with doses ranging between 100 nM to 500 nM of eitherrecombinant rat a-CGRP or b-CGRP (Figures 6A and 6B), which
are nearly identical at the amino acid level (Emeson et al., 1989),
we found that insulin release was greatly blunted. In particular,
100 nM a-CGRP treatment significantly reduced insulin release
by 46% and 500 nM b-CGRP by 58% of the maximum insulin
response. Human a-CGRP also exhibited significant blockade
of the insulin response, albeit to a lesser extent (Figure S4A).
Furthermore, treatment with 100 nM to 500 nM substance P
did not alter insulin secretion of MIN6 cells, suggesting that
CGRP’s effect on insulin secretion is specifically mediated by a
CGRP receptor (Figure 6C). Interestingly, CGRP did not inhibit
the potentiation of glucose-stimulated insulin secretion under
high glucose by incretins as observed upon challenge with
Exendin 4 (Figure S4B). These data confirm previous observa-
tions that CGRP inhibits glucose-mediated insulin secretion
from pancreatic b cells (Ahre´n et al., 1987; Kogire et al., 1991).
CGRP Homeostasis Modulates Metabolic Health
The pathogenesis of type 2 diabetes involves a low-grade
inflammation, which might continuously stimulate TRPV1 neu-
rons and therefore putatively sustain CGRP release and exacer-
bation of the inflammatory response (Suri and Szallasi, 2008).
Consistent with these results, we observed a trend toward lower
levels of inflammatory markers including chemokines and pro-
inflammatory genes in brain and muscle tissue from TRPV1
mutant mice (Figure S4C). Similarly, aging results in chronic
low-grade inflammation (Woods et al., 2012) and increased
levels of circulating CGRP have been detected in aged rats (Mel-
nyk and Himms-Hagen, 1995). Taken together, decreased levels
of circulating CGRP might be beneficial for improved metabolic
function and longevity, while high levels might be detrimental. To
test this hypothesis, we measured circulating CGRP levels in
serum from control and TRPV1 mutant mice (Figure 6D). As
observed in rats, we found that serum levels of CGRP increase
by 42% with age in WT mice (6 versus 24 months). However,
and rather strikingly, this increase was blocked in TRPV1 mutant
mice. In fact, CGRP levels remain unchanged between young
and old TRPV1 mutant mice.
To ask whether increased CGRP might be detrimental to
health of older animals, we challenged old wild-type mice with
the CGRP receptor antagonist, CGRP8-37 (Poyner et al., 1998),
in an effort to restore CGRP homeostasis (Figures 6E and 6F).
After 6 weeks of treatment, we found that the old mice displayed
a reappearance of a more youthful metabolic circadian shift from
night to day indicative of metabolic rejuvenation as measured by
their RER, contrary to vehicle-treated control mice. As observed
in the TRPV1 mutant mice, oxygen consumption was also
increased in CGRP8-37-treated mice compared to controls.
These data indicate that pharmacological inhibition of the
CGRP pathway is sufficient to restore metabolic youth in old an-
imals and counteract the natural CGRP accumulation with age
that is detrimental to wild-type animals.
DISCUSSION
Although it has been shown that genetic manipulation of the
CRTC1/CREB pathway modulates aging of C. elegans (Dong
et al., 2007; Mair et al., 2011) and that disruption ofCell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc. 1031
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Figure 6. CGRP Is a Neuroendocrine Regu-
lator of Metabolism
(A–C) Insulin secretion assay of mouse insulinoma
cells (MIN6) upon 16.8 mM glucose stimulation.
Cells were incubated with 0.1–0.5 mM synthetic
peptides for (A) rat CGRPa, (B) rat CGRPb, and (C)
rat. Substance P, n = 4, means ± SEM, **p < 0.01,
*p < 0.05, Student’s t test.
(D) Serum levels of CGRP measured by ELISA in
blood samples from WT and TRPV1 mutants at
3 and 24 months, n = 7, means ± SEM a, ns; b,
p < 0.05.
(E and F) Respiratory exchange ratio (RER) analysis
(E) and oxygen consumption (F) of 23-month-old
male WT animals treated with CGRP8–37 or vehicle
control, n = 10, means ± SEM,**p < 0.01, *p < 0.05,
Student’s t test.
(G) Model for the neuroendocrine regulation of
metabolism by TRPV1 expressing neurons. Stimu-
lation of TRPV1 by external stimuli promotes CGRP
secretion from DRG neurons onto the pancreatic b
cells and inhibition of insulin release. TRPV1 acti-
vation results in calcium influx and activation of
calcineurin, allowing dephosphorylation of CRTC1
and release from 14-3-3 proteins, resulting in nu-
clear internalization of CRTC1 and transcription of
its targets, such as CGRP. CGRP accumulation has
detrimental effects on energy expenditure, glucose
tolerance, and aging. In contrast, loss of TRPV1
promotes lifespan extension through increased
insulin secretion, metabolic health by inactivating of
the CRTC1/CREB signaling cascade.
See also Figure S4.chemosensory perception extends lifespan in worms and flies
(Alcedo and Kenyon, 2004; Apfeld and Kenyon, 1999; Libert
et al., 2007), whether similar mechanisms regulate mammalian
longevity were unknown. The results presented here provide
evidence that genetic deletion of TRPV1, an ion channel crit-
ical for nociception, extends mouse and C. elegans lifespan
by regulating the activity of CRTC1 in peripheral sensory
neurons.1032 Cell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc.Given the existing precedents linking
TRPV1 to metabolism, we characterized
the insulin metabolism of these mice in
depth. Using a combination of in vivo
and in vitro approaches, we found that
TRPV1 mutant animals have improved
glucose tolerance and increased energy
expenditure throughout aging, despite a
mild insulin resistance. Except for the
latter, these phenotypes could underlie
the exceptional longevity of these mice.
It should be noted that insulin resistance
has been observed in a variety of long-
lived mice associated with improved
glucose tolerance (Kurosu et al., 2005;
Selman et al., 2008; Taguchi et al., 2007)
and therefore is not necessarily an indica-
tor of poor health or lifespan shortening.Energy expenditure, on the opposite, has emerged as a puta-
tive longevity biomarker, as associated with lifespan extension
(Ortega-Molina et al., 2012; Speakman et al., 2004). Improved
energy expenditure throughout aging prevents systemic dam-
age associated from fat storage and fat metabolism by ensuring
a healthier transition between carbohydrate and fat meta-
bolism. Consistent with improved energy expenditure, TRPV1
mutant mice present beneficial effects on glucose tolerance
and resistance to obesity induced by high-fat diet (Motter and
Ahern, 2008). Interestingly, a decrease in cancer incidence of
neoplastic lymphoid origin has been previously associated
with increased energy expenditure and increased lifespan as
observed in the TRPV1 mutant mice (Ortega-Molina et al.,
2012), reinforcing the connection between improved energy
expenditure and youthful aging.
Because CGRP is secreted locally from TRPV1 fibers in the
pancreas, our data argue in favor of a role of TRPV1 on lifespan
by modulating peripheral nervous system function, rather than
for a role in the brain where TRPV1 is also present and affects
hippocampal synaptic plasticity (Cha´vez et al., 2010; Marsch
et al., 2007). Additionally, the weak presence of TRPV1 in neuro-
glia (Mezey et al., 2000; Sasamura et al., 1998) could underlie a
contribution of glial cells to assist DRG neurons in regulating in-
sulin secretion from pancreatic islets. Consistent with peripheral
neuronal control, previous research supports a direct role of
TRPV1 neurons in antagonizing insulin secretion in the b cells
through release of CGRP (Gram et al., 2005; 2007; Pettersson
et al., 1986), suggesting that the improved cognitive function
observed in TRPV1 mutant mice is more likely due to improved
healthspan in these mice rather than the loss of TRPV1 in the
hippocampus.
How does TRPV1 regulate the aging process in sensory neu-
rons? Interestingly, disruption of calcium homeostasis in neu-
rons is observed with aging and documented in the context of
age-related hippocampal dysfunction, a highly age-sensitive
structure (Moreno et al., 2012; West, 1993; West et al., 1994).
TRPV1 activation induces calcium influx in neurons, leading to
calcium-mediated signal transduction, including activation of
CaMK and PKC isoenzymes. Therefore, preserving calcium bal-
ance by disrupting TRPV1 signaling is likely to be beneficial.
Because calcium- and cAMP-dependent pathways that control
gene expression share many common players and points of
crosstalk ultimately leading in the phosphorylation of CREB at
serine 133 and transcriptional activation, the CREB pathway
regulated by its coactivator CRTC1, constitutes a highly
likely candidate to integrate TRPV1 signals. Findings in both
C. elegans and mouse primary DRG neurons strongly support
a role for CRTC in shuttling in and out the nucleus in a calci-
neurin-dependent manner to mediate calcium- and cAMP-
dependent, phosphorylation-independent activation of CREB.
Our results further demonstrate that the silencing of CREB tran-
scriptional regulation affects the synthesis of the CREB target
CGRP.
Remarkably, we and others have observed that CGRP levels
increase drastically with age (Melnyk and Himms-Hagen,
1995), and could contribute to the development of age-associ-
ated type 2 diabetes by blocking insulin secretion from b cells.
Consistent with this hypothesis, low-grade inflammation is asso-
ciated with age-onset type 2 diabetes and proinflammatory
agents might stimulate TRPV1 neurons causing sustained
CGRP release and a higher state of inflammation leading to
aggravated diabetes. Therefore, sustained high CGRP levels
are likely to negatively impact on b cell function and metabolic
health. In contrast, the maintenance of low CGRP levels
achieved by the TRPV1 mutant mice or drug treatment with the
CGRP receptor antagonist CGRP8–37, is associated with ayouthful metabolism in old mice, a delay in age-associated
disease and increased longevity.
Taken together, these findings illustrate that TRPV channels
function in sensory neurons as an evolutionary conserved sys-
tem integrating multiple sensory inputs and transducing them
into neuroendocrine signals that promote longevity by adjusting
the metabolic activity through the CRTC1/CREB circuit. In
particular, these data highlight the role of the neuropeptide
CGRP as a critical neuroendocrine regulator of longevity in
mammals and possible biomarker of predictive lifespan and
healthspan. Interestingly, the extremely long-lived naked mole
rat, which lives over 30 years, is naturally lacking CGRP in
DRGs (Park et al., 2003). The pharmacological manipulation of
TRPV1 and/or CGRP might not only be useful for pain but also
to improve glucose homeostasis and aging. Consistent with
this idea, diets rich in capsaicin, which can over stimulate
TRPV1 neurons and cause their death, have long been linked
to lower incidents of diabetes and metabolic dysregulation in
humans (Westerterp-Plantenga et al., 2005).
EXPERIMENTAL PROCEDURES
Mice and Diet
The longevity study was generated from homozygous TRPV1 mutants
(Caterina et al., 2000) backcrossed 11 times to C57BL/6J and wild-type
(WT) C57BL/6J breeder pairs both obtained from the Jackson Laboratory.
Mice were housed in groups of two to five same-sex littermates under path-
ogen-free conditions, with ad libitum access to water and chow (PicoLab
Rodent 20 5053*, LabDiet). Individuals were monitored daily and weighed
monthly, but were otherwise left undisturbed until they died. Survival was
assessed using male and female mice, and all animals were dead by the
time of this report. Kaplan-Meier survival curves were constructed using
known birth and death dates, and differences between groups were evaluated
using the log-rank test. All procedures were approved by the Institutional
Animal Care and Use Committees (IACUC) of The Salk Institute for Biological
Studies and UC Berkeley.
Metabolic Studies
Indirect calorimetric studies were conducted in a Comprehensive Lab Animal
Monitoring System (Columbus Instruments). For GTT and GSIS, glucose
(2 g/kg weight) was intraperitoneally administered and blood glucose was
measured from tail bleeds at indicated times after injection using a One Touch
Ultra glucometer (LifeScan). For the ITT, 5 hr fasted mice were injected with
1 u/kg of human insulin (Humulin; Eli Lily) and glucose was measured as in
the GTT. Insulin-stimulated signaling in liver and muscle tissue was performed
as previously described (Jordan et al., 2011). Osmotic pumps (Alzet) diffusing
CGRP8–37 (Tocris Bioscience) at 5.5 mg/ml were implanted in 22-month-old
C57BL/6J males (National Institute of Aging).
Quantitative PCR Analysis and Protein Analysis
Pancreatic islets were isolated as previously described (Huising et al., 2010).
DRGs (25–40) were excised from each mouse and homogenized in TriZol.
RNA was isolated using TriZol/chloroform extraction and RNEasy QIAGEN
columns. RNA was converted into cDNA using QuantiTect reverse-transcrip-
tion kit. Gene expression was assessed by qRT-PCR using SYBR green.
Primers sequences are listed in Table S4.
Cell Culture Studies
MIN6 insulinoma cells were cultured as previously described (Huising et al.,
2010). DRG neurons were dissociated by trituration in papain after collagenase
treatment and seeded on a monolayer of cortical astrocytes. Neurons were
pretreated 4 hr with TTX (1 mM) prior either vehicle control or antagonist
blockade (2 hr) followed by 1 hr drug stimulation supplemented withCell 157, 1023–1036, May 22, 2014 ª2014 Elsevier Inc. 1033
Leptomycin B to inhibit nuclear export. Cap, FSK, and Leptomycin B were ob-
tained from Sigma-Aldrich, SB366791 and TTX from Tocris Biosciences, and
CsA from Calbiochem. Neurons were then fixed in 4% paraformaldehyde in
PBS and prepared for immunohistochemistry. All antibodies are detailed in
the Extended Experimental Procedures.
C. elegans Experiments
osm-9(ky4), ocr-2(ak47), and N2 strains were obtained from the Caenorhab-
ditis Genetics Center. AGD418 (N2; uthIs205 [Pcrtc-1::crtc-1::RFP::unc-54
30UTR, rol-6]) and AGD466 (N2, uthEX222 [crtc-1p::crtc-1 cDNA (S76A,
S179A)::tdTOMATO::unc-54 30UTR; rol-6(su1006)]) were generated elsewhere
(Mair et al., 2011).
Full methods and associated references are available in the online version of
the paper.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and four tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.03.051.
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